OneMedNet Reports Over 25% Expansion of iRWD™ Network, Encompassing Clinical Data alongside Aggregate Health Economics and Social Determinant Insights from 5 Billion Administrative Records, Fueling Growth in AI-Powered Healthcare Data

Core Insights - OneMedNet Corporation has achieved a greater than 25% expansion of its proprietary iRWD™ network and platform, enhancing its operational capacity and growth trajectory with the addition of over 5 billion administrative records [1][8] - The company is responding to the rising demand for high-quality longitudinal data and insights into health economics and social determinants of health, particularly for underserved populations [2][8] - OneMedNet's iRWD™ network now includes over 1,750 healthcare sites, providing access to 34 million patients and 136 million clinical exams, positioning the company for significant revenue growth through increased data licensing and enterprise partnerships [8] Company Overview - OneMedNet is a leader in AI-powered Real-World Data (RWD), utilizing its iRWD™ platform to harness data from healthcare sites, which fuels innovation in drug development and medical devices [5] - The company emphasizes the importance of clinical integrity in Real-World Evidence, enabling stakeholders in life sciences and healthcare to generate actionable insights reflective of real-world care delivery [4] - The RWE industry is valued at $60 billion, and OneMedNet aims to be at the forefront of this transformation, making evidence generation faster and more effective [4] Market Position - The expansion of OneMedNet's network reinforces its position as a premier data partner, laying the foundation for accelerated revenue generation and customer acquisition [3][8] - The company’s proprietary AI technology anonymizes data for various industries, including finance and retail, showcasing its versatility beyond healthcare [6]